Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 305
Filtrar
1.
Aesthet Surg J ; 44(5): NP347-NP353, 2024 Apr 04.
Artigo em Inglês | MEDLINE | ID: mdl-38299374

RESUMO

BACKGROUND: Laser hair removal (LHR) is one of the most requested cosmetic procedures worldwide. A rare side effect is the appearance of excess hair around previously treated areas, known as paradoxical hypertrichosis. OBJECTIVES: The aim of this study was to retrospectively identify the cause of this side effect. METHODS: This study included all patients who underwent LHR at our center between November 2018 and November 2020. Alexandrite laser hair removal (HR) or diode laser super hair removal (SHR) was performed in 70% and 30% of cases, respectively. Clinical features and daily habits of patients with and without postlaser hypertrichosis were compared. RESULTS: Of the 7381 patients who received LHR, 25 patients (0.34%) demonstrated an increase in hair growth compared to baseline. Of these 25 patients, 24 had been treated with alexandrite laser HR (P < .01). The most common site was the upper arm, followed by the periareolar area. Daily sun protection was associated with a significantly lower incidence of hypertrichosis (P < .05), as was confirmed and shown to be independent of Fitzpatrick skin type by binary logistic regression analysis (odds ratio = 0.41, P < .05). CONCLUSIONS: In our clinic, we observed paradoxical hypertrichosis after laser hair removal in a small minority of cases, as described by others. We did not observe differences in incidence related to skin type, but daily sun protection and LHR with diode laser SHR were associated with significant reductions in incidence rates. In addition to previously reported common sites, we also identified the periareolar area as a high-risk region.


Assuntos
Remoção de Cabelo , Hipertricose , Terapia a Laser , Humanos , Hipertricose/epidemiologia , Hipertricose/etiologia , Remoção de Cabelo/efeitos adversos , Remoção de Cabelo/métodos , Estudos Retrospectivos , Extremidade Superior , Lasers , Terapia a Laser/efeitos adversos
2.
J Pak Med Assoc ; 73(7): 1539-1541, 2023 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-37469078

RESUMO

Juvenile dermatomyositis (JDM) is a rare autoimmune disease characterised by inflammation of muscles and skin with extra muscular involvement of joints, heart, intestine, and liver. Pathogenesis of JDM is believed to be due to vasculopathy. Along with classic cutaneous features of JDM, rare findings include hypertrichosis, lipoatrophy, photosensitivity, bullous lesions, and hyperhidrosis. We present, here, a case of JDM with hypertrichosis as very few cases have been reported previously.


Assuntos
Dermatomiosite , Hipertricose , Doenças Vasculares , Humanos , Dermatomiosite/complicações , Dermatomiosite/diagnóstico , Hipertricose/diagnóstico , Hipertricose/etiologia , Hipertricose/patologia , Pele/patologia , Inflamação/patologia
3.
J Fam Pract ; 71(6): E7-E9, 2022 07.
Artigo em Inglês | MEDLINE | ID: mdl-35994763

RESUMO

The patient's dermatologic symptoms and his history of a particular chronic condition pointed toward the diagnosis.


Assuntos
Cisto Epidérmico , Hipertricose , Mãos , Humanos , Hipertricose/diagnóstico , Hipertricose/etiologia , Extremidade Superior
4.
Dermatol Ther ; 35(7): e15548, 2022 07.
Artigo em Inglês | MEDLINE | ID: mdl-35502558

RESUMO

Becker's nevus (BN) manifests as a hyperpigmented, sometimes hypertrichotic plaque/patch over the chest and shoulder, and it is in the category of benign cutaneous hamartomas. BN has elongation and fusion of the rete ridge, keratotic plugging, sebaceous hyperplasia, smooth muscle hyperplasia, and hyperpigmentation of the basal/suprabasal layer histologically. This article highlights all issues involved in pathogenesis and treatment options of BN. According to current research, postzygotic ACTB mutations induce BN and Becker's nevus syndrome (BNS). Although several therapy strategies were utilized to treat the pigmentary and hypertrichotic aspects of BN, no definitive standard treatment was identified to far, and further research is needed to better educate BN care.


Assuntos
Hiperpigmentação , Hipertricose , Nevo Sebáceo de Jadassohn , Neoplasias Cutâneas , Doença Crônica , Humanos , Hiperpigmentação/etiologia , Hiperplasia/etiologia , Hipertricose/etiologia , Hipertricose/genética , Nevo Sebáceo de Jadassohn/diagnóstico , Nevo Sebáceo de Jadassohn/terapia , Neoplasias Cutâneas/etiologia , Neoplasias Cutâneas/genética
5.
Clin Exp Dermatol ; 47(8): 1613-1616, 2022 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-35636973

RESUMO

A 6-year-old girl presented with an enlarging asymptomatic nodule within a hyperpigmented hypertrichotic patch on her left thigh. Histopathological examination revealed tumour cells with round to fusiform nuclei in a fine fibrillary collagenous stroma, along with increased cellularity. Most of the tumour cells were positive for S-100 and negative for HMB-45 and Melan-A.


Assuntos
Hiperpigmentação , Hipertricose , Neoplasias Cutâneas , Criança , Feminino , Humanos , Hipertricose/etiologia , Neoplasias Cutâneas/patologia , Coxa da Perna/patologia
6.
Arch. pediatr. Urug ; 92(2): e307, dic. 2021. ilus, tab
Artigo em Espanhol | LILACS, UY-BNMED, BNUY | ID: biblio-1339135

RESUMO

Las porfirias son un grupo complejo y heterogéneo de defectos en la vía de la síntesis del hemo. La porfiria hepato eritropoyética es un subtipo muy poco frecuente y de presentación en la infancia, con compromiso cutáneo predominante. Describimos el caso clínico de una paciente de 5 años, que se presenta con lesiones cutáneas e hipertricosis, se confirma el diagnóstico por elevación de uroporfirinas en orina y secuenciación del gen UROD.


Porphyria is a complex and heterogeneous group of heme synthesis disorder. Hepato-erythropoietic porphyria is a very rare subtype that onsets in childhood, and shows predominant skin involvement. We describe the clinical case of a 5-year-old patient who showed skin lesions and hypertrichosis and whose diagnosis was confirmed due to increased uroporphyrins in urine and UROD gene sequencing


A porfiria é um grupo complexo e heterogêneo de distúrbios da síntese do grupo heme. A porfiria hepato-eritropoiética é um subtipo muito raro que se inicia na infância e mostra envolvimento predominante da pele. Descrevemos o caso clínico de uma paciente de 5 anos que apresentou lesões cutâneas e hipertricose e cujo diagnóstico foi confirmado por aumento de uroporfirinas na urina e sequenciamento do gene UROD.


Assuntos
Humanos , Feminino , Pré-Escolar , Vesícula/etiologia , Porfiria Hepatoeritropoética/complicações , Porfiria Hepatoeritropoética/genética , Porfiria Hepatoeritropoética/urina , Diabetes Mellitus Tipo 1/complicações , Hipertricose/etiologia , Uroporfirinogênio Descarboxilase/análise , Uroporfirinas/urina , Vesícula/tratamento farmacológico , Coproporfirinas/urina , Hipertricose/tratamento farmacológico
7.
Pediatrics ; 148(6)2021 12 01.
Artigo em Inglês | MEDLINE | ID: mdl-34845496

RESUMO

A pediatric dermatology expert working group performed a narrative review to describe care related to congenital melanocytic nevi (CMN) in neonates and infants. There are no published guidelines for most aspects of care, including routine skin care and visit intervals. Few guidelines exist for surgical management; newer recommendations favor conservative practice. Emerging evidence contributes to recommendations for screening MRI to evaluate for neural melanosis and related central nervous system complications, however, more research is needed. Risk for melanoma is generally low, but those with large, giant, or multiple CMN have a higher risk. Multidisciplinary care, with a focus on family and patient preferences, is of paramount importance. Without standardized screening and management guidelines, questions abound regarding appropriate physical examination intervals, potential treatment including full or partial excision, timing and frequency of imaging, melanoma risk, and assessment for neural melanosis. This review highlights the current state of knowledge concerning care of patients with CMN, reveals gaps in the literature surrounding skin care, and provides management recommendations. We additionally discuss cutaneous complications of CMN, such as pruritus, hypertrichosis, and wound healing. Resources and references for families and providers can help patients navigate this sometimes challenging diagnosis. Finally, we contribute expert care recommendations to the current body of literature as a foundation for the development of future, more comprehensive care guidelines.


Assuntos
Nevo Pigmentado/congênito , Nevo Pigmentado/terapia , Neoplasias Cutâneas/congênito , Neoplasias Cutâneas/terapia , Remoção de Cabelo , Humanos , Hipertricose/etiologia , Hipertricose/terapia , Recém-Nascido , Imageamento por Ressonância Magnética , Melanose/diagnóstico por imagem , Síndromes Neurocutâneas/diagnóstico por imagem , Nevo Pigmentado/complicações , Nevo Pigmentado/patologia , Exame Físico , Prurido/etiologia , Higiene da Pele/métodos , Neoplasias Cutâneas/complicações , Neoplasias Cutâneas/patologia , Cicatrização
9.
Am J Clin Dermatol ; 22(5): 615-624, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-34057666

RESUMO

BACKGROUND: Paradoxical hypertrichosis (PH) is an uncommon, poorly understood adverse effect associated with laser or intense pulsed light treatment for hair removal. OBJECTIVE: The objective of this study was to conduct a systematic review and meta-analysis to determine PH prevalence and associated risk factors. METHODS: We conducted a systematic review and meta-analysis of studies evaluating hair removal with lasers or intense pulsed light. Primary outcome was PH prevalence. Meta-regression and subgroup analysis were used to investigate associations among treatment modality, patients' characteristics, and PH. RESULTS: Included were 9733 patients in two randomized controlled trials and 20 cohort studies (three prospective and 17 retrospective). Pooled PH prevalence was 3% (95% confidence interval 1-6; I2 = 97%). Paradoxical hypertrichosis was associated with a face or neck anatomic location, and occurred in only 0.08% of non-facial/neck cases. Treatment modality and interval between treatments had no effect on the PH rate. There were insufficient data to determine the association between sex and skin type to PH. In three out of four studies, PH gradually improved with continued therapy. CONCLUSIONS: Based primarily on cohort studies, PH occurs in 3% of patients undergoing hair removal with lasers or intense pulsed light, yet rarely outside the facial/neck areas. Treatment modality does not seem to be a contributing factor. Continuation of treatment in areas with PH may be the most appropriate treatment.


Assuntos
Folículo Piloso/fisiopatologia , Remoção de Cabelo/efeitos adversos , Hipertricose/etiologia , Terapia a Laser/efeitos adversos , Humanos , Terapia com Luz de Baixa Intensidade/efeitos adversos , Fototerapia/efeitos adversos , Medição de Risco , Fatores de Risco , Índice de Gravidade de Doença
11.
Domest Anim Endocrinol ; 74: 106531, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-32942194

RESUMO

It remains unclear how pituitary pars intermedia dysfunction (PPID) and pergolide treatment (Prascend [pergolide tablets]) affect endocrine and immune function in horses. To evaluate these effects, blood was collected regularly from 28 university-owned horses (10 Non-PPID, 9 PPID control [PC], and 9 PPID treatment [PT]) over approximately 15 mo. Pergolide treatment was initiated after Day 0 collections. Analyses included ACTH, insulin, total cortisol, free cortisol, complete blood counts, plasma myeloperoxidase, and cytokine/receptor gene expression in basal whole blood and in vitro stimulations (PMA/ionomycin, heat-inactivated Rhodococcus equi, and heat-inactivated Escherichia coli) of whole blood and peripheral blood mononuclear cells (PBMCs). The results were analyzed using a linear mixed model (SAS 9.4) with significance set at P < 0.05. Significant group (P = 0.0014) and group-by-time (P = 0.0004) effects were observed in resting ACTH such that PT horses differed from Non-PPID horses only at Day 0. PT horses had significantly lower changes in ACTH responses to thyrotropin-releasing hormone stimulation tests than PC horses at non-fall time points only, mid-late February 2018 (P = 0.016) and early April 2018 (P = 0.0172). When PT and PC horses did not differ, they were combined before comparison to Non-PPID horses. No significant group or group-by-time effects were seen in resting insulin, total cortisol, or free cortisol; however, significant time effects were observed in these measures. PPID horses had lower absolute lymphocyte (P = 0.028) and red blood cell (P = 0.0203) counts than Non-PPID horses. In unstimulated whole blood, PPID horses had increased IL-8 expression compared with Non-PPID horses (P = 0.0102). In addition, PPID horses had decreased interferon γ production from PBMCs after stimulation with R. equi (P = 0.0063) and E. coli (P = 0.0057) and showed increased transforming growth factor ß expression after E. coli stimulation (P = 0.0399). The main limitations of this study were a limited sample size and an inability to truly randomize the PPID horses into treatment groups. Resting ACTH is likely the best choice for determining successful responses to pergolide. Neither PPID nor pergolide appears to influence insulin, total cortisol, and free cortisol. As measured, systemic immune function was altered in PPID horses, and it is likely that these horses are indeed at increased risk of opportunistic infection. Despite reducing ACTH, pergolide treatment did not appear to influence immune function.


Assuntos
Doenças dos Cavalos/tratamento farmacológico , Pergolida/uso terapêutico , Doenças da Hipófise/veterinária , Adeno-Hipófise Parte Intermédia/metabolismo , Hormônio Adrenocorticotrópico/sangue , Hormônio Adrenocorticotrópico/metabolismo , Animais , Relação Dose-Resposta a Droga , Feminino , Doenças dos Cavalos/sangue , Cavalos , Hipertricose/tratamento farmacológico , Hipertricose/etiologia , Hipertricose/veterinária , Masculino , Pergolida/administração & dosagem , Doenças da Hipófise/complicações , Doenças da Hipófise/tratamento farmacológico
16.
Medicine (Baltimore) ; 99(16): e19813, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32311999

RESUMO

RATIONALE: Wiedemann-Steiner syndrome (WDSTS, online mendelian inheritance in man 605130) is a rare autosomal dominant disorder characterized by hypertrichosis cubiti. Here, we report a Chinese boy who do not show the characteristic of hypertrichosis cubiti, and was misdiagnosed as blepharophimosis-ptosis-epicanthus inversus syndrome at first. We found a de novo frameshift mutation (p.Glu390Lysfs*10) in the KMT2A gene, which was not reported before. Our study increases the cohort of Chinese WDSTS patients, and expand the WDSTS phenotypic and variation spectrum. PATIENT CONCERNS: The patient demonstrated typical craniofacial features of blepharophimosis-ptosis-epicanthus inversus syndrome, including small palpebral fissures, ptosis, telecanthus, and epicanthus inversus, besides he had congenital heart disease (ventricular septal defects), strabismus, hypotonia, amblyopia, delayed speech and language development, delayed psychomotor development, and amblyopia (HP:0000646) which was not reported before. DIAGNOSIS: FOXL2 gene was cloned and sequenced, however, there was no mutation detected in this patient. The result of Chromosomal microarray analysis was normal. The patient was diagnosed as WDSTS by whole exome sequencing. INTERVENTIONS: The patient received cardiac surgery, frontalis suspension and regular speech and occupational therapy. He also treated with growth hormone (GH). OUTCOMES: The patient's symptoms are improved after cardiac surgery and frontalis suspension, he can express himself well now and had a 10 cm gain in height. LESSONS: As the relationship between genotype and phenotype becomes more and more clear, WES is incredibly powerful tool to diagnose the disease of WDSTS.


Assuntos
Anormalidades Múltiplas/genética , Blefarofimose/diagnóstico , Contratura/genética , Transtornos do Crescimento/diagnóstico , Transtornos do Crescimento/genética , Cardiopatias Congênitas/diagnóstico , Histona-Lisina N-Metiltransferase/genética , Hipertricose/congênito , Deficiência Intelectual/genética , Microcefalia/genética , Proteína de Leucina Linfoide-Mieloide/genética , Anormalidades da Pele/diagnóstico , Anormalidades Urogenitais/diagnóstico , Anormalidades Múltiplas/diagnóstico , Anormalidades Múltiplas/terapia , Povo Asiático/genética , Criança , Contratura/diagnóstico , Contratura/terapia , Erros de Diagnóstico , Facies , Genótipo , Transtornos do Crescimento/etiologia , Transtornos do Crescimento/terapia , Hormônio do Crescimento/uso terapêutico , Cardiopatias Congênitas/cirurgia , Humanos , Hipertricose/diagnóstico , Hipertricose/etiologia , Deficiência Intelectual/diagnóstico , Deficiência Intelectual/terapia , Masculino , Microcefalia/diagnóstico , Microcefalia/terapia , Mutação , Fenótipo , Resultado do Tratamento , Sequenciamento do Exoma/métodos
18.
Ophthalmic Genet ; 40(5): 453-454, 2019 10.
Artigo em Inglês | MEDLINE | ID: mdl-31584310

RESUMO

When encountering patients with markedly dilated and tortuous retinal vessels, Wyburn-Mason syndrome (WMS) or racemous angiomatosis (phacomatosis) is commonly thought of as the archetypal entity that can produce these findings. We describe a patient with Cantu syndrome with phenotypical findings identical to those seen in patients with WMS and want to highlight this as another entity that can present with tortuous and dilated retinal vessels.


Assuntos
Cardiomegalia/etiologia , Hipertricose/etiologia , Malformações Arteriovenosas Intracranianas/complicações , Osteocondrodisplasias/etiologia , Artéria Retiniana/anormalidades , Vasos Retinianos/anormalidades , Cardiomegalia/patologia , Feminino , Humanos , Hipertricose/patologia , Malformações Arteriovenosas Intracranianas/genética , Pessoa de Meia-Idade , Mutação , Osteocondrodisplasias/patologia , Prognóstico , Receptores de Sulfonilureias/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...